@misc{10481/82946,
year = {2023},
month = {4},
url = {https://hdl.handle.net/10481/82946},
organization = {Junta de Andalucía (CTS 164)},
organization = {Instituto de Salud Carlos III (Spain)},
organization = {Fondo Europeo de Desarrollo
Regional (FEDER)},
organization = {European Union, through the research
grants PI18/00826, P18-RT-4930, PI0206–2016, PIE16/00045 and
PI19/01058},
organization = {Spanish Ministry of Science and Innovation (MCIN/AEI/
10.13039/501100011033/FEDER)},
organization = {RTI2018–101309-BC22},
organization = {Chair “Doctors Galera-Requena in cancer stem cell
research” (CMC-CTS963},
organization = {Spanish Ministry of Science and Innovation (“Programa de
Doctorado: Medicina Clínica y Salud Pública” B12.56.1).},
organization = {Instituto de Salud Carlos III
(FI17/00176)},
organization = {Junta de Andalucía
(P18-RT-4930)},
organization = {University
of Granada},
organization = {CIBER-EHD is funded by the Instituto de Salud Carlos
III},
publisher = {Elsevier},
keywords = {Colitis-associated colorectal cancer},
keywords = {Tigecycline},
keywords = {β-catenin},
keywords = {Cytotoxic T lymphocytes},
keywords = {Microbiota},
title = {Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response},
doi = {10.1016/j.biopha.2023.114760},
author = {Ruiz Malagón, Antonio Jesús and Hidalgo García, Laura and Rodríguez Sojo, María Jesús and Molina Tijeras, José Alberto and Díez Echave, Patricia and Vezza, Teresa and Rodríguez Cabezas, María Elena and Rodríguez Nogales, Alba and Gálvez Peralta, Julio Juan},
}